The detection of PIK3CA mutations in archival or fresh tumor tissue and plasma-derived circulating tumor DNA (ctDNA) is dependent on analytical and methodological factors, thus possibly affecting clinical validity and utility [10]. Here, PIK3CA is linked to neoplasm.